Category - Executive Moves

Executive Moves

Enzo Biochem appoints Matthew Kupferberg as general counsel

Enzo Biochem (NYSE:ENZ) named Matthew Kupferberg as the company’s in-house general counsel. He was most recently general counsel, chief compliance officer and privacy officer of Digital Medical Technologies, a...

August 3, 2022

Executive Moves

DURECT names Timothy Papp as CFO

DURECT (NASDAQ:DRRX) appointed Timothy Papp as chief financial officer to direct and oversee all financial and capital markets activities, including accounting, financial reporting, financial planning and analysis...

July 5, 2022

Executive Moves

Zymeworks names Paul Moore as CSO

Zymeworks (NYSE:ZYME) is strengthening its senior leadership team with the appointment of Paul Moore, Ph.D., as chief scientific officer, reporting directly to the CEO, effective July 18. Dr. Moore brings more than 25...

June 28, 2022

Executive Moves

Hepion adds accomplished biopharmaceutical executives Anand Reddi and Dr. Kaouthar Lbiati to board

Anand Reddi, M.S. Hepion Pharmaceuticals (NASDAQ:HEPA) appointed Anand Reddi, M.S., and Kaouthar Lbiati, M.D., to its board of directors, effective immediately. “Mr. Reddi and Dr. Lbiati have a remarkable wealth...

June 28, 2022

Executive Moves

Hepion names accomplished life sciences veteran Launa Aspeslet as COO

Hepion Pharmaceuticals (NASDAQ:HEPA) appointed Launa Aspeslet, Ph.D., RAC, as chief operating officer to support the company’s rencofilstat clinical program. A versatile C-level executive with more than 25 years of...

June 14, 2022

Executive Moves

Soricimed names scientific, academic leader Dr. Rodney Ouellette to SAB

Rodney Ouellette Soricimed Biopharma appointed one of Atlantic Canada’s leading cancer researchers, Rodney Ouellette, M.D. and Ph.D., to its scientific advisory board. “Rodney has dedicated his life’s work...

June 2, 2022

Executive Moves

MindMed names Schond Greenway as CFO

Schond Greenway Mind Medicine (NASDAQ:MNMD; NEO:MMED) appointed Schond Greenway as CFO. He comes to MindMed with more than 20 years of experience in investment banking, finance and corporate advisory, and investment...

May 24, 2022

Executive Moves

Soricimed Biopharma adds deep public markets experience to team with appointment of healthcare veteran Frank Michalargias as CFO

Frank Michalargias Closely-held Soricimed Biopharma, an oncology drug developer, appointed healthcare industry veteran Frank Michalargias as CFO. In a finance and operations leadership career spanning more than 25...

May 16, 2022

Executive Moves

Qualigen Therapeutics names Shishir Sinha to lead diagnostics division

Shishir Sinha Qualigen Therapeutics (NASDAQ:QLGN) appointed Shishir Sinha, the company’s newly promoted SVP and current COO, to lead its diagnostics division, FastPack. “With the return of the sales and...

April 29, 2022

Executive Moves

Sigyn Therapeutics names hepatology leader Dr. Donald Hillebrand to SAB

Dr. Donald Hillebrand Sigyn Therapeutics (OTC:SIGY) appointed Dr. Donald Hillebrand, M.D., to its scientific advisory board. Dr. Hillebrand is the associate medical director of liver transplantation at Saint...

April 26, 2022

Category - Executive Moves

Enzo Biochem appoints Matthew Kupferberg as general counsel

DURECT names Timothy Papp as CFO

Zymeworks names Paul Moore as CSO

Hepion adds accomplished biopharmaceutical executives Anand Reddi and Dr. Kaouthar Lbiati to board

Hepion names accomplished life sciences veteran Launa Aspeslet as COO

Soricimed names scientific, academic leader Dr. Rodney Ouellette to SAB

MindMed names Schond Greenway as CFO

Soricimed Biopharma adds deep public markets experience to team with appointment of healthcare veteran Frank Michalargias as CFO

Qualigen Therapeutics names Shishir Sinha to lead diagnostics division

Sigyn Therapeutics names hepatology leader Dr. Donald Hillebrand to SAB

General

More